Patents Assigned to NEURALIS SA
  • Publication number: 20230056994
    Abstract: The present invention concerns methods to identify RIPK1 modulators capable of modulating RIPK1 activity, RIPK1 interacting molecules that modulate RIPK1 activity and pharmaceutical compositions comprising RIPK1 modulators.
    Type: Application
    Filed: December 21, 2020
    Publication date: February 23, 2023
    Applicant: NEURALIS SA
    Inventors: Mukherjee SUMEDHA, Kumar GAURAV